CARDIOL THERAPEUTICS EQS-News: Cardiol Therapeutics begins Phase II study of CardiolRx for treatment of recurrent pericarditis
Transparency directive : regulatory news
16/12/2022 18:26
|
EQS-News: Cardiol Therapeutics
 Contact DetailsProactive Canada Proactive Canada +1 604-688-8158 na-editorial@proactiveinvestors.com News Source: News Direct
16.12.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
| Language: | English |
| Company: | Cardiol Therapeutics |
| United States | |
| ISIN: | CA14161Y2006 |
| EQS News ID: | 1515789 |
| End of News | EQS News Service |
|
|
1515789 16.12.2022 CET/CEST
CARDIOL THERAPEUTICS's latest news
27/02/2024 14:16
19/01/2024 12:41
30/08/2023 15:06
24/05/2023 13:01
11/04/2023 15:26
16/12/2022 18:26
14/05/2022 09:01
10/02/2022 12:21
16/11/2021 11:01
11/10/2021 14:02
Other stories
29/04/2024 14:21
29/04/2024 13:59
29/04/2024 12:17
29/04/2024 13:21
29/04/2024 12:43
29/04/2024 06:38
29/04/2024 07:58
29/04/2024 11:32
29/04/2024 10:10
29/04/2024 05:47
29/04/2024 10:09
29/04/2024 12:53
29/04/2024 05:07
29/04/2024 14:28
29/04/2024 14:32
29/04/2024 14:45
29/04/2024 10:16
29/04/2024 13:31
29/04/2024 00:32
29/04/2024 12:56
28/04/2024 08:02
29/04/2024 15:00
William and Kate Middleton release unseen wedding photo to mark anniversary - live - The Independent
29/04/2024 14:19
29/04/2024 12:59
29/04/2024 13:47
29/04/2024 14:16
29/04/2024 13:00
29/04/2024 14:13
29/04/2024 14:22
29/04/2024 12:14
28/04/2024 19:21
29/04/2024 06:02
27/04/2024 20:48
28/04/2024 12:18
29/04/2024 13:08
28/04/2024 08:51
29/04/2024 09:00